You are here: Industry Insights > stock

News List

Sanofi to sell stake in Regeneron pharmatimes
May 27, 2020
Sanofi has revealed its intent to sell its equity investment in Regeneron through a registered public offering and related share repurchase by the firm.
Supernus’ stocks down once more, despite positive phase 3 ADHD data for SPN-812 fiercebiotech
December 29, 2018
Supernus Pharmaceuticals unveiled topline results from two phase 3 studies of children with attention deficit hyperactivity disorder but failed to wow investors worried about how its nonstimulant treatment would take on already-established generics.....
Talc lawyer says J&J's multibillion-dollar stock woes make settling look like a better deal fiercepharma
December 24, 2018
What's bad for Johnson & Johnson shares is good for the trial lawyer leading the charge in the talc liability litigation—or so the lawyer says, as J&J scrambles to contain the damage from a bombshell Reuters report Friday.
Talc lawyer says J&J's multibillion-dollar stock woes make settling look like a better deal fiercepharma
December 24, 2018
What's bad for Johnson & Johnson shares is good for the trial lawyer leading the charge in the talc liability litigation—or so the lawyer says, as J&J scrambles to contain the damage from a bombshell Reuters report Friday.
Teva proposes to buy Mylan for $40.1 billion biospectrumasia
November 16, 2018
He added that Mylan's business is a natural fit with Teva and is highly complementary to it. Merging the two companies would not only deliver the greatest value
Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock biospace
April 18, 2018
Bellicum Pharmaceuticals, Inc.today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock.
Eleven Biotherapeutics Announces Pricing of $10.0 Million Offering Priced At-the-Market biospace
March 22, 2018
Eleven Biotherapeutics announced today that it has reached a definitive agreement with several institutions and accredited investors.
Spherix Announces Pricing of $3 Million Public Offering of Common Stock biospace
March 16, 2018
Spherix Incorporated today announced that it has priced a registered public offering on a "best efforts" basis of an aggregate of 2,222,222 shares of common stock at a price to the public of $1.35 per share.
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock prnasia
March 12, 2018
VolitionRx Limited announced today the pricing of its previously announced underwritten public offering of 3,500,000 shares of common stock at a public offering price of $2.40 per share.
Aytu BioScience Announces Closing of $12,000,000 Public Offering biospace
March 07, 2018
Aytu BioScience, Inctoday announced the closing of its previously announced underwritten public offering for total gross proceeds of $12,000,000, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

Previous page 1 2 Next page